Axsome Therapeutics, Inc. (AXSM) — Stock Score Summary

Axsome Therapeutics, Inc. (AXSM) has a MoatMap StockRank of 63/100 based on Quality (30/100), Value (35/100), and Momentum (83/100) factor scores. The current signal is HOLD. Axsome is a speculative biotech company with binary clinical and commercial risks that do not align with our focus on high-ROIC, asset-light compounders with predictable cash flows.

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system (CNS) disorders, with a pipeline addressing areas like depression, migraine, and narcolepsy. The company's competitive advantage stems from its innovative product candidates and proprietary technology designed to enhance drug efficacy and safety. Axsome seeks to address significant unmet medical needs in large and growing CNS markets, holding multiple FDA-approved products.

Key Financial Metrics

Price$245.64
Market Cap$12.0B
P/E (Forward)39.32
Price/Book217.97
Return on Equity-349.4%
Return on Invested Capital-57.0%
Debt/Equity402.84
Gross Margin92.6%
Operating Margin-32.8%
Revenue Growth57.4%
Free Cash Flow$-4M

Axsome Therapeutics, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Axsome Therapeutics, Inc.’s (AXSM) StockRank?
MoatMap’s StockRank for Axsome Therapeutics, Inc. (AXSM) is 63/100, with a Hold signal. It is a composite of Quality (30), Value (35), and Momentum (83) factor ranks across MoatMap’s 19,000+ stock universe.
Does Axsome Therapeutics, Inc. have an economic moat?
Axsome Therapeutics, Inc. (AXSM) has a Quality factor score of 30/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Axsome Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Axsome Therapeutics, Inc. (AXSM) is Hold, based on a StockRank of 63/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. (AXSM) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksAXSM deep dive reportAI ChampionsHow we score stocksSense-check another stock